AIM ImmunoTech Inc. (AIM)

AMEX: AIM · Real-Time Price · USD

0.09

-0.03 (-23.53%)

At close: Apr 04, 2025, 10:10 AM

AIM ImmunoTech Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	170K	202K	141K	135K	163K	140K	367K	437K	92K
Cost of Revenue	31K	42K	19.92M	850K	806K	893K	884K	1.18M	1.11M
Gross Profit	139K	160K	-19.78M	-715K	-643K	-753K	-517K	-746K	-1.02M
Operating Income	-19.77M	-31.92M	-19.92M	-18.84M	-15.15M	-12.44M	-11.5M	-11.42M	-13.8M
Interest Income	5.19M	n/a	629K	67K	219K	89K	46K	88K	129K
Pretax Income	-17.32M	-28.96M	-19.45M	-19.13M	-14.4M	-9.53M	-9.81M	-8.26M	-7.5M
Net Income	-17.32M	-28.96M	-21.09M	-21.51M	-16.26M	-10.83M	-9.81M	-8.26M	-7.5M
Selling & General & Admin	13.71M	21.14M	13.07M	8.67M	8.65M	7.04M	6.2M	6.57M	7.68M
Research & Development	6.2M	10.94M	6.99M	7.67M	5.72M	4.65M	4.78M	4.1M	5.11M
Other Expenses	n/a	n/a	1.49M	2.32M	1.19M	866K	277K	3.21M	2.87M
Operating Expenses	19.91M	32.08M	20.06M	16.34M	14.37M	11.69M	10.98M	10.67M	12.79M
Interest Expense	585K	n/a	n/a	67K	672K	427K	502K	139K	129K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	19.94M	32.12M	20.06M	17.19M	15.18M	12.58M	11.86M	11.85M	13.9M
Income Tax Expense	n/a	n/a	1.64M	2.39M	1.86M	1.29M	2.19M	3.35M	134K
Shares Outstanding (Basic)	56.02M	48.59M	48.05M	47.34M	31.84M	3.64M	1M	651.72K	495.86K
Shares Outstanding (Diluted)	56.02M	48.59M	48.05M	47.34M	31.84M	3.64M	1M	651.72K	495.86K
EPS (Basic)	-0.31	-0.6	-0.44	-0.45	-0.51	-2.97	-9.77	-12.67	-15.13
EPS (Diluted)	-0.31	-0.6	-0.44	-0.45	-0.51	-2.97	-9.77	-12.67	-15.13
EBITDA	-16.49M	-31.68M	-19.87M	-18.25M	-13.02M	-8.15M	-8.4M	-7.12M	-6.33M
EBIT	-16.73M	-31.92M	-19.92M	-19.06M	-13.73M	-8.98M	-9.32M	-8.12M	-7.5M
Depreciation & Amortization	246K	238K	-424K	805K	706K	829K	920K	1M	1.17M